Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study is Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study. The purpose is to determine the safety, tolerability, systemic exposure and pharmacokinetics of ME1111 after repeated daily topical application of ME1111 in a maximal use setting in adults with distal subungual onychomycosis of the toenails.
Epistemonikos ID: f08660d1bcdf26eeae553c2846d235f9666cd5ae
First added on: May 11, 2024